Incidence and prognostic importance of silent ischaemia after PTCA: a prospective study
C Gohlke1, H Gohlke, J Petersen
1Rehabilitationszentrum für Herz- und Kreislaufkranke, Bad Krozingen, F.R.G.
Insights
Percutaneous transluminal coronary angioplasty (PTCA) significantly reduced ischemic episodes, but silent ischemia persisted in some patients. Further research is needed to understand the causes of persistent silent ischemia post-PTCA.
Area of Science:
- Cardiology
- Interventional Cardiology
Background:
- Ischemic episodes, both symptomatic and silent, are key indicators of coronary artery disease.
- Percutaneous transluminal coronary angioplasty (PTCA) is a common intervention for managing coronary artery disease.
Purpose of the Study:
- To assess the impact of successful PTCA on symptomatic and asymptomatic ischemic episodes.
- To investigate the characteristics and implications of persistent or newly occurring silent ischemia after PTCA.
Main Methods:
- Prospective evaluation of 94 patients undergoing successful PTCA.
- 24-hour ambulatory electrocardiographic Holter monitoring before and after PTCA.
- Analysis of ischemic episode frequency, duration, and type (symptomatic vs. silent).
Main Results:
- Successful PTCA significantly reduced the total number and duration of ischemic episodes.
- While symptomatic episodes decreased markedly, silent ischemic episodes showed less improvement.
- Silent ischemia post-PTCA was not linked to inadequate dilatation or increased risk of restenosis.
Conclusions:
- PTCA effectively reduces overall ischemic burden but does not eliminate silent ischemia.
- Persistent silent ischemia may relate to increased vascular tone in susceptible individuals.
- Silent ischemia post-PTCA requires further investigation for underlying mechanisms and clinical significance.
Abstract:
To evaluate the influence of PTCA on symptomatic and asymptomatic ischaemic episodes in 94 patients, 24-h ambulatory, electrocardiographic Holter recordings were obtained before and after successful PTCA. Sixty-four per cent of patients had one-vessel disease, 28% two-vessel disease and 8% had three-vessel disease. Ischaemic episodes were present in 36% of patients before PTCA, of which 71% were silent; after PTCA, 23% of patients had ischaemic episodes, of which 98% were silent; thus silent ischaemic episodes were improved by PTCA to a lesser degree than symptomatic ischaemic episodes. Successful PTCA lead to a significant reduction in total number and duration of ischaemic episodes but not to a complete abolition. Patients with silent ischaemic episodes after PTCA had also a higher incidence of silent ischaemic episodes before PTCA. Functional and haemodynamic improvement was comparable in patients with and without silent ischaemic episodes. No specific cause for the persistent or newly appearing silent ischaemic episodes after PTCA could be identified; they are not indicative of an inadequate dilatation and cannot be considered as a risk factor for early restenosis. A possible explanation could be a traumatically induced, increased vascular tone in susceptible patients.
Related Concept Videos
01:25Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
01:27Coronary Artery Disease V: Interprofessional Care
01:30Acute Coronary Syndrome III: Diagnostic Studies
01:27Angina II: Classification
01:27Atherosclerosis II: Clinical Manifestations and Diagnostic Tests